Featured Posts

Tuesday, February 5, 2019

Akonni Biosystems Awarded Phase II NIH Contract to Advance its Device to Purify DNA from Sputum for Tuberculosis Testing

FREDERICK, Md., Feb. 5, 2019 /PRNewswire/ -- Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx systems, today announced receipt of a $3 million, three-year Phase II Small Business Innovation Research (SBIR) contract...



from PR Newswire: https://prn.to/2MPZxP3

No comments:

Post a Comment